Project Grant R35DE034348

Award Date 9/20/24
Completion Date 6/30/32
Dollars Obligated $3.1M
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
This National Institute of Dental and Craniofacial Research (NIDCR) Project Grant award under the Oral Diseases and Disorders Research program (CFDA 93.121) provides $320,053 to the University of Southern California (USC) to conduct comprehensive research on the craniofacial skeleton and connective tissue development. The 8-year project will utilize advanced techniques in spatial transcriptomics and mouse genetics to identify genes and pathways regulating the assembly of the craniofacial...
This federal Project Grant award, valued at $294,000 and spanning September 2024 to September 2026, was provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research (CFDA 93.121) program. The grant supports research to understand the mechanisms of craniofacial cartilage differentiation from human neural crest stem cells, with the goal of developing tissue engineering approaches to repair birth defects and injuries to the head and...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will provide $429,000.00 to the Regents of the University of Michigan to conduct research on the unique characteristics of jawbone biology. The research aims to gain a molecular-level understanding of how osteoblasts in the jawbone respond differently to bone morphogenetic protein (BMP) signaling and mechanical loading...
This federal Project Grant award, valued at $161,762.00 and awarded by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), supports research on the role of the NG2/CSPG4 protein in the healing of endochondral fractures in the mandible. The research aims to define the specific molecular pathways by which NG2/CSPG4 regulates the differentiation of osteochondral progenitor cells during fracture repair, with the...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $606,296 project grant (CFDA 93.121 - Oral Diseases and Disorders Research) to the University of Missouri System on May 1, 2025. The grant supports a 5-year research project to develop state-of-the-art, three-dimensional growth models of the craniofacial complex using advanced cone-beam computed tomography (CBCT) imaging. The goal is to create new growth standards that incorporate the three-dimensional nature of the...
This Project Grant from the National Institute of Dental and Craniofacial Research (NIDCR), part of the Department of Health and Human Services, will fund research into the genetic basis of human skeletal facial morphology through July 2025. Provided under the Oral Diseases and Disorders Research program (CFDA 93.121), the $936,510 in funding will support two key aims. First, the awardee will enhance current mesh landmarking procedures for craniofacial bone by developing a dense quasi-landmark...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $452,681 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to The Regents of the University of California, San Francisco (UCSF) for the project "Control of Mammalian Craniofacial Morphogenesis by the ESCRT Machinery". The research aims to determine the tissue-specific roles of the ESCRT machinery in regulating signaling pathways and lipid metabolism during mammalian...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $619,304.36 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to The Children's Hospital Corporation (doing business as Boston Children's Hospital) to conduct research on mapping and predicting the effects of transcription factor dosage on craniofacial morphology and disease. The project aims to develop tools to precisely modulate the dosage of craniofacial transcription factors in...
This Project Grant award of $1,722,291.00 from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will fund the development of novel metformin-releasing injectable scaffolds to enhance dental pulp stem cell-based regeneration of critical-sized craniofacial bone defects. The University of Maryland, Baltimore is the prime awardee. The key objectives are to: (1) demonstrate that metformin's osteogenic and...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a Project Grant (CFDA 93.121 - Oral Diseases and Disorders Research) totaling $690,625 to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The grant, awarded on August 12, 2024, will support research to explore whether the FDA-approved iron oxide nanoparticle formulation ferumoxytol can activate orofacial mesenchymal stem/progenitor cells (OMSCs) and...

This Project Grant award of $3,069,994.00 from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research Federal Grant Program (CFDA 93.121), supports a multi-faceted research program focused on elucidating the role of skeletal stem cell plasticity in craniofacial bone diseases. The primary awardee, the University of Texas Health Science Center at Houston, will investigate the fates and functions of periosteal and endosteal stem cells in load-bearing craniofacial bones under normal and regenerative conditions, as well as mechanisms regulating chondrocyte plasticity in the cranial base synchondrosis and mandibular condylar cartilage. Additionally, the program will explore in-depth molecular and cellular mechanisms governing skeletal stem cell plasticity in two novel craniofacial bone disease models: idiopathic condylar resorption (endochondral) and osteonecrosis of the jaw (intramembranous). The research program aims to establish skeletal stem cell dysregulation as a fundamental tenet of craniofacial bone diseases, which can serve as a critical therapeutic target. The University of Michigan is a sub-awardee supporting specific aspects of this research program.

Generated 7/15/25, 10:17 AM